These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33550084)

  • 1. Synthesis and biological evaluation of a ring analogs of the selective CB2 inverse agonist SMM-189.
    Alghamdi SS; Mustafa SM; Moore Ii BM
    Bioorg Med Chem; 2021 Mar; 33():116035. PubMed ID: 33550084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of (3',5'-dichloro-2,6-dihydroxy-biphenyl-4-yl)-aryl/alkyl-methanone selective CB2 inverse agonist.
    Presley CS; Mustafa SM; Abidi AH; Moore BM
    Bioorg Med Chem; 2015 Sep; 23(17):5390-401. PubMed ID: 26275680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor, visual and emotional deficits in mice after closed-head mild traumatic brain injury are alleviated by the novel CB2 inverse agonist SMM-189.
    Reiner A; Heldt SA; Presley CS; Guley NH; Elberger AJ; Deng Y; D'Surney L; Rogers JT; Ferrell J; Bu W; Del Mar N; Honig MG; Gurley SN; Moore BM
    Int J Mol Sci; 2014 Dec; 16(1):758-87. PubMed ID: 25561230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of visual deficits and visual system pathology after mild TBI with the cannabinoid type-2 receptor inverse agonist SMM-189.
    Guley NM; Del Mar NA; Ragsdale T; Li C; Perry AM; Moore BM; Honig MG; Reiner A
    Exp Eye Res; 2019 May; 182():109-124. PubMed ID: 30922891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist.
    Presley C; Abidi A; Suryawanshi S; Mustafa S; Meibohm B; Moore BM
    Pharmacol Res Perspect; 2015 Aug; 3(4):e00159. PubMed ID: 26196013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverse Agonism of Cannabinoid Receptor Type 2 Confers Anti-inflammatory and Neuroprotective Effects Following Status Epileptics.
    Yu Y; Li L; Nguyen DT; Mustafa SM; Moore BM; Jiang J
    Mol Neurobiol; 2020 Jun; 57(6):2830-2845. PubMed ID: 32378121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and structure-activity relationships of diindolylmethane derivatives as cannabinoid CB
    Mahardhika AB; Ressemann A; Kremers SE; Gregório Castanheira MS; Schoeder CT; Müller CE; Pillaiyar T
    Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200493. PubMed ID: 36437108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist.
    Bu W; Ren H; Deng Y; Del Mar N; Guley NM; Moore BM; Honig MG; Reiner A
    Front Neurosci; 2016; 10():449. PubMed ID: 27766068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB
    Navarro G; Varani K; Lillo A; Vincenzi F; Rivas-Santisteban R; Raïch I; Reyes-Resina I; Ferreiro-Vera C; Borea PA; Sánchez de Medina V; Nadal X; Franco R
    Pharmacol Res; 2020 Sep; 159():104940. PubMed ID: 32470563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective Cannabinoid 2 Receptor Stimulation Reduces Tubular Epithelial Cell Damage after Renal Ischemia-Reperfusion Injury.
    Pressly JD; Mustafa SM; Adibi AH; Alghamdi S; Pandey P; Roy KK; Doerksen RJ; Moore BM; Park F
    J Pharmacol Exp Ther; 2018 Feb; 364(2):287-299. PubMed ID: 29187590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development of cannabinoid CBII receptor agonists for the treatment of central neuropathies.
    Rivers JR; Ashton JC
    Cent Nerv Syst Agents Med Chem; 2010 Mar; 10(1):47-64. PubMed ID: 20236042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Celastrol is a novel selective agonist of cannabinoid receptor 2 with anti-inflammatory and anti-fibrotic activity in a mouse model of systemic sclerosis.
    Jiang X; Chen S; Zhang Q; Yi C; He J; Ye X; Liu M; Lu W
    Phytomedicine; 2020 Feb; 67():153160. PubMed ID: 31901889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid type-2 receptor agonist, inverse agonist, and anandamide regulation of inflammatory responses in IL-1β stimulated primary human periodontal ligament fibroblasts.
    Abidi AH; Alghamdi SS; Dabbous MK; Tipton DA; Mustafa SM; Moore BM
    J Periodontal Res; 2020 Oct; 55(5):762-783. PubMed ID: 32562275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1/M2 polarization through the cAMP/PKA pathway in an experimental GMH rat model.
    Tao Y; Li L; Jiang B; Feng Z; Yang L; Tang J; Chen Q; Zhang J; Tan Q; Feng H; Chen Z; Zhu G
    Brain Behav Immun; 2016 Nov; 58():118-129. PubMed ID: 27261088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of novel tri-aryl CB2 selective cannabinoid ligands.
    Bhattacharjee H; Gurley SN; Moore BM
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1691-3. PubMed ID: 19230659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing pyridazine-3-carboxamides to be CB2 agonists: The design, synthesis, structure-activity relationships and docking studies.
    Qian HY; Wang ZL; Xie XY; Pan YL; Li GJ; Xie X; Chen JZ
    Eur J Med Chem; 2017 Sep; 137():598-611. PubMed ID: 28651225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of the cannabinoid CB(2) receptor as a pharmacological target against inflammation in Parkinson's disease.
    Gómez-Gálvez Y; Palomo-Garo C; Fernández-Ruiz J; García C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():200-8. PubMed ID: 25863279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabichromene is a cannabinoid CB
    Udoh M; Santiago M; Devenish S; McGregor IS; Connor M
    Br J Pharmacol; 2019 Dec; 176(23):4537-4547. PubMed ID: 31368508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling.
    Ma L; Jia J; Liu X; Bai F; Wang Q; Xiong L
    Biochem Biophys Res Commun; 2015 Feb; 458(1):92-7. PubMed ID: 25637536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure activity relationship investigation of triazolo[1,5-a]pyrimidines as CB2 cannabinoid receptor inverse agonists.
    Aghazadeh Tabrizi M; Baraldi PG; Ruggiero E; Saponaro G; Baraldi S; Poli G; Tuccinardi T; Ravani A; Vincenzi F; Borea PA; Varani K
    Eur J Med Chem; 2016 May; 113():11-27. PubMed ID: 26922225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.